News Square
Global Crypto News · Real-time Aggregation
📚 Deep Analysis
More →GRVT Burns 1.1 Million Tokens as Countdown to Grvt 2.0 Begins
<strong>[PRESS RELEASE – Singapore, Singapore, October 20th, 2026]</strong> <strong>The discretionary buyback represents close to 1% of circulating supply and precedes four planned product milestones culminating in Grvt 2.0.</strong> <a href="https://grvt.io/" rel="nofollow noopener" target="_blank">>Grvt</a>, a self-custodial trading platform built on its own zero-knowledge (ZK) chain, announced that the Foundation’s token issuer has completed its first GRVT token buyback, purchasing and burning 1.1 million GRVT tokens on the open market. The transaction permanently removed close to 1% of GRVT’s circulating supply at the time of purchase. It marks the first of five milestones ahead of the planned launch of Grvt 2.0 at the end of November 2026. <strong>A Discretionary Buyback with On-Chain Verification</strong> The Foundation’s token issuer intends to conduct further buybacks on a monthly basis. Each transaction remains entirely at the issuer’s discretion, with no predetermined purchase amount or guaranteed schedule. Buybacks are executed through an independent execution partner, with purchased tokens transferred to a designated burn address and permanently removed from circulation. The transactions can be independently verified through the <a href="https://grvt.io/exchange/buybacks" rel="nofollow noopener" target="_blank">>public buyback dashboard</a>, which records the number of tokens purchased and burned, the percentage of circulating supply represented, cumulative burns and on-chain transaction hashes. “The GRVT token is an important part of the ecosystem we are building,” said <strong>Hong, co-founder and CEO of Grvt</strong>. “We welcome the issuer’s buybacks as a demonstration of its long-term commitment to the ecosystem and community. Grvt is expanding its products and markets, and the issuer’s buybacks sit alongside that as a supportive mechanism aimed at reducing circulating token supply.” <strong>Grvt Outlines Four Product Milestones</strong> The announcement follows GRVT’s token generation event in July 2026 and precedes a series of planned launches. <strong>Grvt Earn, scheduled for the End of October,</strong> will introduce yield opportunities backed by tokenized assets, with target yields of up to 11%. Potential returns are expected to derive from underlying asset cash flows, including interest, premiums and invoice-related income. Asset-supplying partners will be announced at launch. Target yields are not guaranteed. <strong>Stable Funding Perps, scheduled for November,</strong> will introduce perpetual futures linked to commodities, stocks, foreign exchange and indices. The contracts are planned to carry zero trading fees and use once-daily funding. Grvt aims to list more than 1,000 markets by the end of December 2026. <strong>Yield as Margin, also scheduled for November,</strong> will allow eligible Grvt Earn balances to support trading positions while continuing to accrue yield, subject to applicable product terms
OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
OpenAI has bought Orchestra Bio, a San Francisco startup whose AI agents help drug companies keep sprawling development programs on schedule, the ChatGPT maker <a href="https://openai.com/index/openai-to-acquire-orchestra-bio/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>announced Tuesday</a>. “Our goal is to help scientists make discoveries and manage the work needed to turn them into treatments that reach patients sooner,” OpenAI said in the announcement. Orchestra’s team and platform will be folded into <a href="https://openai.com/rosalind/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>Rosalind</a>, OpenAI’s family of AI models and tools for biologists and chemists. The financial terms were not disclosed. Getting a new medicine from first idea to U.S. approval takes time—up to 15 years according to OpenAI. Every month shaved off that timeline is a month earlier that a new treatment can reach the people waiting for it, and a month earlier that the company can generate cash. The process is also absurdly expensive: bringing one approved drug to market can cost more than <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12668846/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>$2.6 billion</a>, and <a href="https://arxiv.org/pdf/2106.05386" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">fewer than 10%</a> of candidates that enter human testing ever make it to pharmacy shelves. Beyond the science itself, OpenAI says drug teams have to coordinate work across internal departments and outside partners, often relying on systems that don’t talk to each other. Those partners usually include contract research organizations, the outside labs hired to run studies, and contract manufacturers that produce the experimental drug. Orchestra’s AI agents—software that can watch over tasks and flag problems on its own—work out which activities and deadlines take the hit, gather the relevant information and compare ways to respond, while scientists and program leaders make the final call. Founded in the fall of 2022, Orchestra raised its <a href="https://jobs.8vc.com/companies/orchestra/jobs/28818089-senior-software-engineer" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>seed round</a> from Andreessen Horowitz, Definition Capital, Insight Partners, and 8VC, and about $20 million in total, according to <a href="https://www.caplight.com/company/orchestra-bio" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">Caplight data</a>. The company should not be confused with Orchestra BioMed, an unrelated Nasdaq-listed medical device maker that trades under the ticker OBIO. In April, OpenAI launched <a href="https://decrypt.co/364783/openai-gpt-rosalind-drug-discovery-life-sciences-model" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">GPT-Rosalind</a>, a model built specifically for biology and dru
OKX launches the "Peace of Mind Shield" account security system, offering protection coverage of up to 500,000 USDT.
CoinWorld news: OKX's brand-new account security system "Anxin Shield" is now officially live, allowing users to check the security status of their accounts and devices with one click and further enhance account security protection by enabling six major security protection items. At the same time, Anxin Shield offers protection coverage of up to 500,000 USDT for eligible account theft losses. In the event of an unauthorized third-party account takeover incident that meets the official terms, users can report it through official channels and submit a compensation claim; specific compensation eligibility and amounts are subject to the official terms and review results. Users can access "Anxin Shield" through the "Assets" tab at the bottom of the OKX APP homepage and the shield icon in the upper right corner to view their account security status and complete the relevant settings.
The number of Nasdaq-listed stocks closing unchanged stands at 217.
CoinWorld US stock data: Nasdaq securities unchanged on the day totaled 217. Compared with the same-caliber snapshot 7 days ago, this is down 21.38%.
Nearly eight months after the attack on the Iranian elementary school, the United States is "still investigating."
BiJie Network News: U.S. Secretary of Defense Hegseth said on the 20th that the United States is still investigating the U.S. military attack on an Iranian elementary school in Minab on February 28 and will release the investigation results in due course. Hegseth said that day: "The investigation is still ongoing. When it is time to release it, we will release it." On the first day of the large-scale military strikes launched by the United States and Israel against Iran this year, an elementary school in Minab in southern Iran was hit by an airstrike, killing more than 170 people, the vast majority of them children.
OpenAI said two of its AI agents weakened internal monitoring systems.
CoinWorld news: OpenAI stated that two of its AI agents weakened an internal monitoring system designed to detect misconduct.
OKX将上线LLYUSD X-合约（X-Perp）
CoinWorld news: OKX has announced that it will officially launch USD-margined X-Perpetual contracts (X-Perp) on its web platform, app, and API on October 21, 2026, at 16:30 (UTC+8).
SPCX perpetual futures rose 7.23%, and the largest long position's unrealized profit increased by $1.1 million.
CoinWorld data: The SPCX perpetual contract on Hyperliquid is trading at $161.72, up 7.23% from $150.81 at 12:30 (UTC+8) when the earnings call began. Trading volume over the past 24 hours was approximately $277 million, and the notional value of open interest is approximately $151 million. Address 0x519c holds approximately 100,100 long positions worth $16.19 million, with an average entry price of $135.602, and unrealized profit of $2.6146 million. This rally has increased its unrealized profit by $1.1 million. SpaceX's third-quarter revenue and profit exceeded expectations, with first-quarter 2027 revenue projected to reach $33 billion to $37 billion, above the $220 million expectation. Musk expects the annualized recurring revenue run rate to rise to $500 billion to $10,000,000 million by the end of 2027, the AI investment payback period to shorten to within one year, and confirmed that SpaceX and Tesla have discussed a potential merger.
MiraclePlus responds to US sanctions: denies investing in Shanghai Zhisuan
Biji.com news, Qi Ji, founder of MiraclePlus, responded to U.S. sanctions, stating that the U.S. Department of the Treasury added some of its affiliated entities to the sanctions list without prior communication. The company explicitly denied investing in Shanghai Zhisuan Technology and said it is communicating with relevant parties in the hope of having the sanctions lifted as soon as possible. The U.S. Department of State said on October 19 that former Google engineer Ding Linwei had participated in the MiraclePlus startup camp with Shanghai Zhisuan Technology, that MiraclePlus provided it with seed funding, and that it obtained equity in the company. A ruling from a federal court in California shows that Ding Linwei entered the MiraclePlus startup camp in August 2023 and received 5 million yuan in financing from its investment arm, corresponding to a 7% equity stake in Zhisuan Technology.
Whales continue to accumulate Bitcoin, with 3 new wallets receiving 1,090 BTC.
CoinWorld data: According to Lookonchain monitoring, whales continue to accumulate Bitcoin, and another 3 newly created wallets received 1,090 BTC from Wintermute, worth approximately $90.38 million at current prices.